Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.

Signal, Brandon; Pérez Suárez, Thalía Gabriela; Taberlay, Phillippa C; Woodhouse, Adele

Signal, Brandon; Pérez Suárez, Thalía Gabriela; Taberlay, Phillippa C; Woodhouse, Adele.

Afiliação

Signal B; School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia. Electronic address: brandon.signal@utas.edu.au.
Pérez Suárez TG; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia.
Taberlay PC; School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.
Woodhouse A; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia.

Neurobiol Dis ; 186: 106284, 2023 10 01.

Article em En | MEDLINE | ID: mdl-37683959

Assuntos

Doença de Alzheimer; Humanos; Doença de Alzheimer/genética; Epigênese Genética; Metilação de DNA; Epigenoma; Encéfalo

Palavras-chave

Alzheimer's disease; Epigenetics; Histones; Methylation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Revista: Neurobiol Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google